Anzeige
Mehr »
Login
Freitag, 08.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus" in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0YKHW | ISIN: US16948K1060 | Ticker-Symbol:
1-Jahres-Chart
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS INC 5-Tage-Chart

Aktuelle News zur CANNABIS BIOSCIENCE INTERNATIONAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoCannabis Bioscience International Holdings: CBIH Welcomes Charles Tamburello to Its Board, Strengthening M&A Strategy139Houston, Texas--(Newsfile Corp. - November 4, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is thrilled to announce the appointment of Mr. Charles Tamburello as a new member of...
► Artikel lesen
31.10.Cannabis Bioscience International Holdings, Inc. - 10-Q/A, Quarterly Report2
28.10.Cannabis Bioscience International Holdings: CBIH Strengthens Competitive Advantage with Rapid Expansion of Patent Filings228Houston, Texas--(Newsfile Corp. - October 28, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) trading on the OTC Markets under the ticker symbol CBIH has reached a major milestone...
► Artikel lesen
21.10.Cannabis Bioscience International Holdings, Inc. - 10-Q, Quarterly Report1
11.10.Cannabis Bioscience International Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB1
14.09.Cannabis Bioscience International Holdings, Inc. - 10-K, Annual Report-
26.08.Cannabis Bioscience International Holdings, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405-
15.07.CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications1
08.07.CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: CBIH Charts Path to Future Leadership in Cannabis Medicine2
08.07.Cannabis Bioscience International Holdings: CBIH: Unleashing the Potential of Cannabis for Tomorrow's Medicine204Houston, Texas--(Newsfile Corp. - July 8, 2024) - Since the start of the year, Cannabis Bioscience International Holdings (OTC Pink: CBIH) has embarked on a transformative journey involving merger...
► Artikel lesen
01.07.Cannabis Bioscience International Holdings: CBIH Submits Groundbreaking Cannabis Patents for Breast and Pancreatic Cancer Treatments428Houston, Texas--(Newsfile Corp. - July 1, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel...
► Artikel lesen
26.06.CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change1
24.06.Cannabis Bioscience International Holdings: CBIH's Recently Appointed Director Unveils Groundbreaking Product Strategies and Potential Partnership with Industry Leader258Houston, Texas--(Newsfile Corp. - June 24, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is thrilled to introduce the groundbreaking strategies formulated by its freshly appointed...
► Artikel lesen
17.06.CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: Unleashing the Potential of Cannabis: Cannabis Bioscience International Holdings Reaches a Historic Valuation1
17.06.Cannabis Bioscience International Holdings: CBIH Achieves $2 Billion Valuation Following StoneBridge Advisory Assessment291Houston, Texas--(Newsfile Corp. - June 17, 2024) - Cannabis Bioscience International Holdings (OTC PINK: CBIH) has been valued at $2 Billion following a rigorous evaluation by StoneBridge Advisory...
► Artikel lesen
05.06.CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward1
05.06.Cannabis Bioscience International Holdings: Vita Biotech Retains CBIH Services for Clinical Studies218Houston, Texas--(Newsfile Corp. - June 5, 2024) - Vita Biotech Research has entered into a significant partnership with Cannabis Bioscience International Holdings (OTC Pink: CBIH), to fund the clinical...
► Artikel lesen
29.05.Cannabis Bioscience International Holdings Engages StoneBridge Advisory for Comprehensive Company Valuation384Houston, Texas--(Newsfile Corp. - May 29, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) announces the engagement of StoneBridge Advisory (stonebridgema.com) for CBIH's company...
► Artikel lesen
20.05.Cannabis Bioscience International Holdings: CBIH Engages Prestigious Law Firm for its First Patent Applications500Houston, Texas--(Newsfile Corp. - May 20, 2024) - Cannabis Bioscience International Holdings(OTC Pink: CBIH), utilizing robust methodologies to safeguard its intellectual property and establish a well-defined...
► Artikel lesen
06.05.Cannabis Bioscience International Holdings: CBIH Welcomes New Treasurer and Director, Mr. John E. Jones431Houston, Texas--(Newsfile Corp. - May 6, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH), a leading company in the cannabis industry, proudly announces Mr. John E. Jones as its...
► Artikel lesen
Seite:  Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1